Tempest Therapeutics (TPST) Institutional Ownership $0.90 +0.03 (+3.45%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tempest Therapeutics (NASDAQ:TPST)CurrentInstitutional OwnershipPercentage22.52%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$406.18KNumber ofInstitutional Sellers(last 12 months)0 Get TPST Insider Trade Alerts Want to know when executives and insiders are buying or selling Tempest Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TPST Institutional Buying and Selling by Quarter Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Tempest Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC220,067$308K0.0%+42.7%0.873% 11/15/2024 XTX Topco Ltd23,989$34K0.0%N/A0.095% 11/5/2024 Empower Advisory Group LLC35,000$49K0.0%N/A0.139% 10/29/2024 Fullcircle Wealth LLC62,000$87K0.0%N/A0.279% 8/9/2024 Dimensional Fund Advisors LP25,084$55K0.0%N/A0.113% 5/20/2024Virtu Financial LLC28,574$112K0.0%+69.2%0.129% Get the Latest News and Ratings for TPST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024 MayTech Global Investments LLC10,000$44K0.0%N/A0.052% 8/14/2023 Rock Springs Capital Management LP536,214$681K0.0%-34.9%4.026% 8/11/2023 Sectoral Asset Management Inc.219,394$279K0.0%N/A1.893% 2/14/2022 Maven Securities LTD77,377$409K0.0%-39.0%1.120% 11/15/2021 Franklin Resources Inc.15,240$221K0.0%N/A0.227% 11/12/2021 Renaissance Technologies LLC34,104$493K0.0%+26.9%0.509% 11/9/2021BlackRock Inc.82,698$1.20M0.0%+1,581.2%1.234% 11/9/2021 Monashee Investment Management LLC60,000$868K0.2%-47.2%0.896% 8/18/2021 Ikarian Capital LLC89,865$1.01M0.1%N/A7.076% 8/17/2021 Boothbay Fund Management LLC10,477$117K0.0%N/A0.825% 8/16/2021 Maven Securities LTD106,628$1.20M0.0%N/A8.396% 8/13/2021 Renaissance Technologies LLC26,867$300K0.0%N/A2.116% 8/13/2021Knott David M13,833$155K0.1%N/A1.089% 8/13/2021 Vanguard Group Inc.61,150$683K0.0%N/A4.815% 8/13/2021 FMR LLC647,898$7.24M0.0%N/A51.016% 8/12/2021 Monashee Investment Management LLC113,644$1.27M0.2%N/A8.948% 5/19/2021 Squarepoint Ops LLC84,879$102K0.0%N/A0.446% 5/17/2021 Ikarian Capital LLC1,348,021$1.62M0.1%+897.1%7.079% 5/17/2021 Goldman Sachs Group Inc.20,883$25K0.0%-50.9%0.110% 5/14/2021 Dimensional Fund Advisors LP51,219$61K0.0%+259.3%0.269% 5/14/2021 Monashee Investment Management LLC500,000$600K0.1%N/A2.626% 5/13/2021 Barclays PLC42,638$51K0.0%-90.8%0.224% 5/13/2021 Renaissance Technologies LLC924,801$1.11M0.0%+66.0%4.856% 5/13/2021Knott David M137,900$165K0.1%N/A0.724% 5/11/2021 Acadian Asset Management LLC291,230$350K0.0%+189.9%1.529% 5/7/2021BlackRock Inc.139,319$167K0.0%+9.8%0.732% 2/24/2021Virtu Financial LLC30,755$66K0.0%N/A0.162% 2/19/2021 JPMorgan Chase & Co.75,264$161K0.0%+8,328.2%0.396% 2/11/2021 Barclays PLC464,390$994K0.0%+355.7%2.444% 2/10/2021 Renaissance Technologies LLC557,108$1.19M0.0%+4.1%2.932% 2/9/2021 Bank of New York Mellon Corp56,397$121K0.0%N/A0.297% 11/19/2020 Schonfeld Strategic Advisors LLC31,600$52K0.0%N/A0.166% 11/17/2020 Schonfeld Strategic Advisors LLC31,600$52K0.0%N/A0.166% 11/16/2020 Great Point Partners LLC1,177,900$1.92M0.2%-19.4%6.199% My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO11/9/2020 Acadian Asset Management LLC99,448$162K0.0%-60.7%0.523% (Data available from 1/1/2016 forward) TPST Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TPST shares? During the previous two years, 9 institutional investors and hedge funds held shares of Tempest Therapeutics. The most heavily invested institutionals were Rock Springs Capital Management LP ($681K), Geode Capital Management LLC ($308K), Sectoral Asset Management Inc. ($279K), Virtu Financial LLC ($112K), Fullcircle Wealth LLC ($87K), Dimensional Fund Advisors LP ($55K), and Empower Advisory Group LLC ($49K).Learn more on TPST's institutional investors. What percentage of Tempest Therapeutics stock is owned by institutional investors? 22.52% of Tempest Therapeutics stock is owned by institutional investors. Learn more on TPST's institutional investor holdings. Which institutional investors have been buying Tempest Therapeutics stock? The following institutional investors have purchased Tempest Therapeutics stock in the last 24 months: Sectoral Asset Management Inc. ($219.39K), Geode Capital Management LLC ($65.83K), Fullcircle Wealth LLC ($62K), Empower Advisory Group LLC ($35K), Dimensional Fund Advisors LP ($25.08K), XTX Topco Ltd ($23.99K), and Virtu Financial LLC ($11.69K). How much institutional buying is happening at Tempest Therapeutics? Institutional investors have bought a total of 452,982 shares in the last 24 months. This purchase volume represents approximately $684.81K in transactions. Which Tempest Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Tempest Therapeutics stock in the last 24 months: Rock Springs Capital Management LP ($287.44K). How much institutional selling is happening at Tempest Therapeutics? Institutional investors have sold a total of 287,440 shares in the last 24 months. This volume of shares sold represents approximately $365.05K in transactions. Related Companies GNLX Major Shareholders ME Major Shareholders CASI Major Shareholders PMVP Major Shareholders ONCY Major Shareholders IKNA Major Shareholders QNCX Major Shareholders CLSD Major Shareholders CMRX Major Shareholders FBLG Major Shareholders This page (NASDAQ:TPST) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
